Exosome RNA Exosome RNA Research & Industry News

Coronary artery disease leading to myocardial infarction (“heart attack”) is a major cause of death worldwide . After a heart attack, the myocardium is unable to regenerate, therefore, the heart ...

Financing round significantly oversubscribed by both new and existing investors Proceeds enable advancement of our exosome therapeutics into the clinic and expansion of our world-leading exosome...

Speaker David Lyden, M.D., Ph.D. Stavros S. Niarchos Professor in Pediatric Cardiology Professor of Pediatrics Cornell University

Small extracellular vesicles (sEVs) are increasingly recognized as noninvasive diagnostic markers for many diseases. Hence, it is highly desirable to isolate sEVs rapidly for downstream molecular analyses. However, conventional methods ...

Ciloa, a pioneer company specialized in the in vivo customization of exosomes, announced today the selection of its project as part of the “Sanofi iTech Awards” program. It is the first time that ...

VivaZome Therapeutics and La Trobe University announced that they have entered into a new collaborative research project focused on developing novel exosome therapeutics. Under the collaborative arrangement, VivaZome scientists will ...

RNA therapeutics have high potential that is yet to be fully realized, largely due to challenges involved in the appropriate delivery to target cells...

Codiak BioSciences, a clinical-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics a...